Skip to content

Study of Congenital Orofacial Clefts by Implementing Optical Genome Mapping

Study of Congenital Orofacial Clefts by Implementing Optical Genome Mapping

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06880094
Acronym
CARTOFENTE
Enrollment
26
Registered
2025-03-17
Start date
2025-02-18
Completion date
2027-04-01
Last updated
2026-01-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Next Generation Sequencing (NGS), Optical Genome Mapping, Orofacial Clefts

Keywords

orofacial clefts, Next Generation Sequencing, Optical Genome Mapping

Brief summary

Orofacial clefts, the most common congenital craniofacial malformations, have a complex etiology involving an interaction between genetic and environmental factors. Chromosomal abnormalities, including structural variations, represent a major cause of human pathology. Recently, technological developments and the introduction of next-generation sequencing (NGS) technologies have revolutionized the field of medical genetics. Optical genome mapping (OGM) is an innovative, high-resolution "long read" technique that enables the identification of all classes of chromosomal variation, consisting in the direct visualization of long, labeled DNA molecules throughout the genome. This technology is gradually becoming an essential tool for studying onco-hematology and constitutional genetic pathologies The purpose of this study is to search for structural chromosomal variants (SV) or copy number variants (CNV) not identifiable either by cytogenetic methods nor by "short read" NGS "short read, in individuals with oral-facial clefts with no genetic diagnosis.

Interventions

GENETICblood withdrawal

blood withdrawal for genetic testing

Sponsors

Centre Hospitalier Universitaire, Amiens
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Individuals with syndromic, complex or familial oral-facial clefts * With no established genetic diagnosis * Followed up at the Amiens-Picardie University Hospital

Exclusion criteria

* genetic diagnosis of oral-facial cleft * No health insurance affiliation * Patient under guardianship or curatorship, under safeguard of justice or deprived under public law * Pregnant, parturient or breast-feeding woman

Design outcomes

Primary

MeasureTime frameDescription
Identification of a structural chromosomal variant2 yearsIdentification of a structural chromosomal variant involved in the genesis of orofacial clefts by studying the genetic characteristics of individuals with orofacial clefts.

Countries

France

Contacts

CONTACTBénédicte DEMEER, MD
Demeer.Benedicte@chu-amiens.fr33+322087581

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026